Ginkgo Bioworks Holdings, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for Ginkgo Bioworks Holdings, Inc. (DNA) is -1.70

According to Ginkgo Bioworks Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.70. This represents a change of -10.83% compared to the average of -1.91 of the last 4 quarters.

Ginkgo Bioworks Holdings, Inc. (DNA) Historical PE Ratio (quarterly & annually)

How has DNA PE Ratio performed in the past?

The mean historical PE Ratio of Ginkgo Bioworks Holdings, Inc. over the last ten years is -30.44. The current -1.70 PE Ratio has changed 458.38% with respect to the historical average. Over the past ten years (40 quarters), DNA's PE Ratio was at its highest in in the June 2024 quarter at -0.76. The PE Ratio was at its lowest in in the September 2020 quarter at -124.94.

Ginkgo Bioworks Holdings, Inc. (DNA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Ginkgo Bioworks Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ginkgo Bioworks Holdings, Inc. (DNA) Average PE Ratio

How has DNA PE Ratio performed in the past?

The current PE Ratio of Ginkgo Bioworks Holdings, Inc. (DNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ginkgo Bioworks Holdings, Inc. (DNA) PE Ratio vs. Peers

How is DNA’s PE Ratio compared to its peers?

Ginkgo Bioworks Holdings, Inc.’s PE Ratio is greater than Iovance Biotherapeutics, Inc. (-4.25), greater than Replimune Group, Inc. (-2.85), greater than MBX Biosciences, Inc. Common Stock (-19.56), greater than MeiraGTx Holdings plc (-7.65), greater than ArriVent BioPharma, Inc. Common Stock (-8.99), greater than Maravai LifeSciences Holdings, Inc. (-7.17), greater than Astria Therapeutics, Inc. (-5.88), greater than Vir Biotechnology, Inc. (-2.93), greater than Arvinas, Inc. (-2.35), greater than Valneva SE (-2.84),

Build a custom stock screener for Ginkgo Bioworks Holdings, Inc. (DNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ginkgo Bioworks Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ginkgo Bioworks Holdings, Inc. (DNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ginkgo Bioworks Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.